Strongylophorines: Natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway

Journal of Medicinal Chemistry

Volumn 51, Issue 5, 2008, Pages 1402-1405

  Mohammed, Kaleem A ^a   Jadulco, Raquel C ^a,b   Bugni, Tim S ^a   Harper, Mary Kay ^a   Sturdy, Megan ^a   Ireland, Chris M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; HYPOXIA INDUCIBLE FACTOR 1; STRONGLYPHORINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; EXTRACT; HUMAN; HUMAN CELL; INVERTEBRATE; MARINE SPECIES; PETROSIA; PETROSIA STRONGLYTA;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; DRUG SCREENING ASSAYS, ANTITUMOR; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; PETROSIA; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41649084741     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm7010854     Document Type: Article

References (30)

1. Nordsmark, M.; Bentzel, S. M.; Overgaard, J. Measurement of human tumor oxygenation status by a polarographic needle electrode. An analysis of inter and intratumour heterogeneity. Acta Oncol. 1994, 33, 383-389.
2. Harris, A. L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2, 38-47.
3. Brizel, D. M.; Scully, S. P.; Harrelson, J. M.; Layfield, L. J.; Bean, J. M.; Prosnitz, L. R.; Dewhirst, M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996, 56, 941-943.
4. Reynolds, T. Y.; Rockwell, S.; Glazer, P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996, 56, 5754-5757.
5. Semenza, G. L.; Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992, 12, 5447-5454.
6. Semenza, G. L.; Wang, G. L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 1993, 268, 21513-21518.
7. Semenza, G. L.; Wang, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270, 1230-1237.
8. Ratcliffe, P. J.; O'Rourke, J. F.; Maxwell, P. H.; Pugh, C. W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 1998, 201, 1153-1162.
9. Blancher, C.; Harris, A. L. The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Cancer Metastasis Rev. 1998, 17, 187-194.
10. Hodges, T.; Hossain, C.; Kim, Y-P.; Zhou, Y-D.; Nagle, D. G. Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1. J. Nat. Prod. 2004, 67, 767-771.
11. Mohammed, K. A.; Hossain, C. F.; Zhang, L.; Bruick, R. K.; Zhou, Y-D.; Nagle, D. G. Laurenditerpenol, a new diterpene from the tropical marine alga Laurencia intricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells. J. Nat. Prod. 2004, 67, 2002-2007.
12. Yeo, E. J.; Chun, Y. S.; Cho, Y. S.; Kim, J.; Lee, J. C.; Kim, M. S.; Park, J. W. YC-1: a potential anticancer drug targeting hypoxia-inducible factor-1. J. Natl. Cancer Inst. 2003, 95, 516-525.
13. Ricker, J. L.; Chen, Z.; Yang, X. P.; Pribluda, V. S.; Swartz, G. M.; Van Waes, C. 2 - Methoxyestradiol inhibits hypoxia-inducible factor 1 alpha tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin. Cancer Res. 2004, 10, 8665-8673.
14. Rapisarda, A.; Uranchimeg, B.; Scudiero, D. A.; Selby, M.; Sausville, E. A; Shoemaker, R. H.; Melillo, G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 2002, 62, 4316-4324.
15. Welsh, S.; Williams, R.; Kirkpatrick, D. L.; Paine-Murrieta, G.; Powis, G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α. Mol.Cancer Ther. 2004, 3, 233-244.
16. Powis, G.; Kirkpatrick, D. L. Hypoxia inducible factor-1α as a cancer drug target. Mol. Cancer Ther. 2004, 3, 647-654.
17. Garber, K. New drugs target hypoxia response in tumors. J. Natl. Cancer Inst. 2005, 97, 1112-1114.
18. Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
19. Verbitski, S. M.; Mullally, J. E.; Fitzpatrick, F. A.; Ireland, C. M. Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J. Med. Chem. 2004, 47, 2067-2070.
20. James, R. D.; Jones, D. A.; Aalbersberg, W.; Ireland, C. M. Naamidine A intensifies the phosphotransferase activity of extracellular signal-regulated kinases causing A-431 cells to arrest in G1. Mol. Cancer Ther. 2003, 2, 747-751.
21. Marshall, K. M.; Matsumoto, S. S.; Holden, J. A.; Concepcion, G. P.; Tasdemir, D.; Ireland, C. M.; Barrows, L. R. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicty of neoamphimedine. Biochem. Pharmacol. 2003, 66, 447-458.
22. Braekman, J. C.; Daloze, D.; Hulot, G.; Tursch, B.; Declercq, J. P.; Germain, G.; Van Meerssche, M. Chemical studies of marine invertebrates. XXXVII. Three novel meroditerpenoids from the sponge Strongylophora durissima. Bull. Soc. Chim. Belg. 1978, 87, 917-926.
23. Salva, J.; Faulkner, D. J. Metabolites of the sponge Strongylophora durissima from Maricaban Island, Philippines. J. Org. Chem. 1990, 55, 1941-1943.
24. Balbin-Oliveros, M.; Edrada, R.; Proksch, P.; Wray, V.; Witte, W. M.; Van Soest, R. W. M. A new meroditerpenoid dimer from an undescribed Philippine marine sponge of the genus Strongylophora. J. Nat. Prod. 1998, 61, 948-952.
25. Liu, H.; Namikoshi, M.; Akano, K.; Kobayashi, H.; Nagai, H.; Yao, X. Seven new meroditerpenoids, from the marine sponge Strongylophora strongylata, that inhibited the maturation of starfish oocytes. J. Asian Nat. Prod. Res. 2005, 7, 661-670.
26. Warabi, K.; McHardy, L. M.; Matainaho, L.; Van Soest, R. W. M.; Roskelley, C. D.; Roberge, M.; Andersen, R. J. Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity. J. Nat. Prod. 2004, 67, 1387-1389.
27. Benlimane, A. F.; Pouches, Y. F.; Le Boterff, J.; Verbist, J. F.; Roussakis, C.; Monniot, F. Substances cytotoxiques et antibacteriennes de l'ascidie Aplidium antillense. J. Nat. Prod. 1988, 51, 582-583.
28. Berkman, R. A.; Merrill, M. J.; Reinhold, W. C.; Monacci, W. T.; Saxena, A.; Clark, W. C.; Robertson, J. T.; Ali, I. U.; Oldfield, E. H. Expression of the vascular permeability factor /vascular endothelial factor gene in central nervous system neoplasms. J. Clin. Invest. 1993, 91, 153-159.
29. Ke, L. D.; Shi, Y. X.; Im, S. A.; Chen, X.; Yung, W. K. The relevance of cell proliferation, vascular endothelial growth factor and basic fibroblast growth factor production to angiogenesis and tumori-genicity in human glioma cell lines. Clin. Can. Res. 2000, 6, 2562-2572.
30. Forsythe, J. A.; Jiang, B. H.; Iyer, N. V.; Agani, F.; Leung, S. W.; Koos, R. D.; Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16, 4604-4613.